MannKind Corp. Company Profile (NASDAQ:MNKD)

Analyst Ratings

Consensus Ratings for MannKind Corp. (NASDAQ:MNKD) (?)
Ratings Breakdown: 4 Sell Rating(s), 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 1.71)
Consensus Price Target: $2.83 (183.74% upside)

Analysts' Ratings History for MannKind Corp. (NASDAQ:MNKD)
Show:
DateFirmActionRatingPrice TargetActions
6/1/2016Royal Bank Of CanadaLower Price TargetUnderperform$1.00 -> $0.15View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Piper Jaffray Cos.Lower Price TargetUnderweight$1.50 -> $0.05View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016JMP SecuritiesReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Goldman Sachs Group Inc.Reiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016S&P Equity ResearchLower Price Target$1.12 -> $0.96View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2016JPMorgan Chase & Co.Reiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016Griffin SecuritiesUpgradeNeutral -> Buy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2015Jefferies GroupReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015MLV & Co.Lower Price TargetHold$7.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for MannKind Corp. (NASDAQ:MNKD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/9/2016Q116($0.04)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2016Q4($0.05)($0.66)$0.35 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.07)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.08)($0.07)$0.53 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.08)($0.08)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414($0.09)($0.09)$3.13 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2014Q314$0.04($0.09)$66.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q214($0.12)($0.19)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114($0.13)($0.14)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2014Q4($0.14)($0.16)$0.43 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2013Q313($0.14)($0.17)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2013Q2 2013($0.14)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.15)($0.15)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2013Q4 2012($0.19)($0.23)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312($0.24)($0.22)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012($0.24)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2012($0.23)($0.27)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2012($0.32)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.32)($0.31)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011($0.30)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2011($0.29)($0.34)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2011($0.40)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MannKind Corp. (NASDAQ:MNKD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.03)($0.03)($0.03)
Q2 20161($0.03)($0.03)($0.03)
Q3 20161($0.03)($0.03)($0.03)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for MannKind Corp. (NASDAQ:MNKD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MannKind Corp. (NASDAQ:MNKD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/17/2016Michael CastagnaInsiderBuy50,000$0.93$46,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015Hakan EdstromCEOSell73,460$4.83$354,811.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2015Hakan EdstromCEOSell73,460$5.21$382,726.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Hakan EdstromCEOSell73,460$7.75$569,315.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015David ThomsonVPSell80,000$7.00$560,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Diane PalumboVPSell188,999$5.95$1,124,544.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014David ThomsonVPSell118,114$6.14$725,219.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Juergen MartensVPSell63,800$5.48$349,624.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Juergen MartensVPSell417$7.60$3,169.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014David ThomsonVPSell30,000$8.16$244,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2014Juergen MartensVPSell26,458$9.65$255,319.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2014Diane PalumboVPSell17,901$10.01$179,189.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Matthew J PfefferCFOSell20,000$10.44$208,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Hakan EdstromCOOBuy1,692$4.42$7,478.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/27/2014Juergen MartensVPSell25,417$10.53$267,641.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2014David ThomsonVPSell30,000$10.51$315,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Juergen MartensVPSell1,458$10.34$15,075.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Diane PalumboVPSell17,902$10.59$189,582.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Juergen MartensVPSell120,000$11.00$1,320,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2014David ThomsonVPSell133,000$9.95$1,323,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014Diane PalumboVPSell52,957$9.50$503,091.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014Juergen MartensVPSell25,000$7.65$191,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Juergen MartensVPSell76,899$7.50$576,742.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Diane PalumboVPSell18,176$7.06$128,322.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014Juergen MartensVPSell50,000$5.56$278,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2013Hakan EdstromCOOBuy1,589$4.53$7,198.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/20/2013Juergen MartensVPSell32,054$5.00$160,270.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2013David ThomsonVPSell150,000$5.00$750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/29/2013Juergen MartensVPSell48,057$5.01$240,765.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Diane PalumboVPSell25,000$5.02$125,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013David ThomsonVPSell19,204$5.78$110,999.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Juergen MartensVPSell20,000$5.52$110,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Matthew J PfefferCFOSell10,000$8.00$80,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2013Matthew J PfefferCFOSell10,000$7.00$70,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2013Diane PalumboVPBuy1,610$1.96$3,155.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2013Matthew J PfefferCFOBuy7,448$1.96$14,598.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Diane PalumboVPSell66,849$7.50$501,367.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Diane PalumboVPSell26,829$5.25$140,852.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Matthew J PfefferCFOSell10,000$5.00$50,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2012Matthew J PfefferCFOBuy1,056$1.95$2,059.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2012Alfred E MannMajor ShareholderBuy40,000,000$2.59$103,600,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for MannKind Corp. (NASDAQ:MNKD)
DateHeadline
07/22/16 08:10 AMMannKind Corporation (MNKD) Stock: One Thing Could Send It Over The Top!
07/21/16 05:28 PMMannKind Corporation (MNKD) Stock: One Thing Could Send It Over The Top! - CNA Finance (press release)
07/21/16 08:05 AMIntraday Active Biotech Stocks News: MannKind Corp. (NASDAQ:MNKD), Juno Therapeutics Inc. (NASDAQ:JUNO) - The Voice Registrar
07/20/16 08:09 AMHot Biotech Stocks Recap: Mast Therapeutics, Inc. (NYSEMKT:MSTX), MannKind Corp. (NASDAQ:MNKD) - The Voice Registrar
07/19/16 05:21 PM2 Biotech Stocks News And Price Trends: MannKind Corp. (NASDAQ:MNKD), Relypsa, Inc. (NASDAQ:RLYP) - The Voice Registrar
07/18/16 05:23 PMHC Stocks Newsbeat: CVS Health Corp (NYSE:CVS) MannKind Corporation (NASDAQ:MNKD) - share market updates (press release)
07/18/16 05:23 PMAnalyst Opinion of: MannKind Corp. (NASDAQ:MNKD) - News Oracle
07/15/16 04:17 PMHC Stocks Growth: MannKind Corporation (NASDAQ:MNKD), Boston Scientific Corporation (NYSE:BSX) - share market updates (press release)
07/15/16 09:39 AMMannKind Corporation (MNKD) Drops 5.31% on July 13 - Equities.com
07/14/16 08:50 AMBiotech Stocks To Put On Your Watch List: MannKind Corp. (NASDAQ:MNKD), BioMarin Pharmaceutical Inc. (NASDAQ ... - The Voice Registrar
07/14/16 08:50 AMBroker Outlook For MannKind Corporation (MNKD) - Fiscal Standard
07/13/16 12:20 PMMannKind Corporation: Can MNKD Stock Rise Above the Pharma Heap? - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips Stark pessimism for MNKD stock is to be expected, but underappreciated factors could bring an unlikely surprise for MannKind. The post MannKind Corporation: Can MNKD Stock Rise Above the Pharma Heap? appeared first on InvestorPlace.
07/13/16 08:10 AMPrice Target in the Spotlight: MannKind Corp. (NASDAQ:MNKD) - News Oracle
07/13/16 08:10 AMTrader Alert: The Allstate Corporation (ALL), MannKind Corp. (MNKD), Calpine Corp. (CPN) - iStreetWire
07/13/16 07:20 AMThe 6 Most Shorted Nasdaq Stocks: Bye-Bye Apple -
07/12/16 05:30 PMMannKind To Present At Cantor Fitzgerald Healthcare Conference;Webcast At 3:30PM
07/11/16 05:15 PMCompany Shares of MannKind Corporation (NASDAQ:MNKD) Drops by -0.85% - TheFounders Daily
07/11/16 05:15 PMNext Weeks Broker Price Targets For MannKind Corporation (MNKD) - Fiscal Standard
07/11/16 03:25 PMWhy MannKind Corp. Stock Rose 17% in June - Recently released data is a feather in Afrezza's cap, but will it be enough?
07/08/16 04:11 PMMannKind Corporation to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference - [at noodls] - VALENCIA, Calif., July 08, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that the Company will present at Cantor Fitzgerald's 2 Annual Healthcare Conference on ...
07/08/16 04:00 PMMannKind Corporation to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference - [GlobeNewswire] - VALENCIA, Calif., July 08, 2016-- MannKind Corporation announced today that the Company will present at Cantor Fitzgerald’ s 2 nd Annual Healthcare Conference on Tuesday, July 12, 2016 at 3:30 PM at the ...
07/07/16 05:16 PMMannKind Corporation (MNKD) Current Analyst Ratings - Fiscal Standard
07/07/16 08:06 AMHC Stocks Buyers Alerts: MannKind Corporation (NASDAQ:MNKD), Abbott Laboratories (NYSE:ABT) - share market updates (press release)
07/07/16 08:06 AMMannKind Corporation (MNKD) Drops 5.08% on July 05 - Equities.com
07/06/16 05:26 PMNotable Wednesday Option Activity: MNKD, CYTR, BMY
06/30/16 05:35 PMMannKind (MNKD) Stock: Don't Miss This Opportunity - Modest Money (press release) (blog)
06/29/16 05:06 PMNew Broker Ratings For MannKind Corporation (MNKD) - FTSE News
06/29/16 05:06 PMAnalysts Review of Stocks: Neovasc Inc. (NASDAQ:NVCN) , MannKind Corporation (NASDAQ:MNKD) - Street Updates
06/27/16 05:07 PMStocks in the News - MannKind Corporation, (NASDAQ:MNKD), Energy Transfer Equity, (NYSE:ETE) - Hot Stocks Point
06/27/16 05:07 PM10 Largest Short Positions In NASDAQ Shocks - 24/7 Wall St.
06/27/16 05:07 PMStock Analysis review: MannKind Corp. (NASDAQ:MNKD) - News Oracle
06/26/16 09:52 AMMannKind (MNKD) Stock Gains While The Market Falls: Here's Why! - aomarkets (registration) (blog)
06/24/16 09:39 AMMannKind Corp. Shares Are Down 28.3% So Far This Year. Here's Why. - A series of announcements have sent the company's shares on a roller coaster ride this year. Here's a recap of what has happened so far, and some advice for investors considering climbing on board.
06/22/16 05:06 PMMannKind Corporation (MNKD) Jumps 10.28% on June 22 - Equities.com
06/22/16 05:06 PMMannKind (MNKD) Stock: Big Gains Ahead! - Modest Money (press release) (blog)
06/22/16 09:58 AMMannKind Corporation (NASDAQ:MNKD) Analyst Rating Consensus - Trade Calls
06/21/16 04:52 PMMannkind Afrezza Launch 2.0: How It Is Different This Time Around - Seeking Alpha
06/20/16 05:15 AMThis Weeks Broker Views For MannKind Corporation (MNKD) - Fiscal Standard
06/19/16 09:15 AMMannKind - Managing Expectations Of An Afrezza Relaunch - Seeking Alpha
06/16/16 05:23 PMNotable Analyst's Ranking Preview: MannKind Corporation (NASDAQ:MNKD) , Allergan plc. (NYSE:AGN) - Street Updates
06/15/16 05:11 PMHC Stocks Analysis: MannKind Corporation (NASDAQ:MNKD), Perrigo Company plc (NYSE:PRGO) - share market updates (press release)
06/14/16 04:58 PMMost Active Stocks Update: MannKind Corp. (NASDAQ:MNKD), Staples, Inc. (NASDAQ:SPLS) - Beacon Chronicle
06/14/16 04:58 PMCompany Update (NASDAQ:MNKD): MannKind Corporation Announces Late-Breaking Data Reinforcing Faster Onset ... - Smarter Analyst
06/14/16 08:48 AMThese Small Cap Stocks Are On The Move -
06/13/16 09:10 AMHow Does MannKind Corporation (MNKD)’s Afrezza Compare With Mealtime Insulin? -
06/13/16 08:08 AMHC Stocks in Front Line: Galena Biopharma Inc (NASDAQ:GALE), MannKind Corporation (NASDAQ:MNKD) - share market updates (press release)
06/12/16 02:09 PMMannKind Announces Late-Breaking Data Reinforcing Faster Onset and Shorter Duration of Action Compared to Mealtime Insulins - [at noodls] - Data presented at ADA show Afrezza has a 25-to 35-minute faster onset of action than Lispro, with a duration that is up to two hours shorter MannKind Corporation reaffirms commitment to Afrezza, the only ...
06/11/16 05:23 PMMannKind Corporation (MNKD) Stock: Collaboration Agreement In Focus - CNA Finance (press release)
06/11/16 07:24 AMIf You Aren't Careful, This Brokerage Fee Could Wipe You Out -
06/10/16 08:34 AMBRIEF-MannKind announces collaboration with JDRF - * MannKind Corp says entered into a collaboration agreement with JDRF

Social

About MannKind Corp.

MannKind Corp. logoMannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a portable inhaler. AFREZZA utilizes its Technosphere formulation technology. Technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics. Technosphere powders are based on the Company's fumaryl diketopiperazine (FDKP), which is a potential of Hydrogen (pH)-sensitive organic molecule that self-assembles into small particles under acidic conditions. The Company has also created a range of breath-powered, dry powder inhalers. Its inhalers can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: MNKD
  • CUSIP: 56400P20
Key Metrics:
  • Previous Close: $1.00
  • 50 Day Moving Average: $1.0797
  • 200 Day Moving Average: $1.1760
  • P/E Ratio: N/A
  • P/E Growth: -0.1600
  • Market Cap: $428.35M
  • Beta: 1.76
  • Current Year EPS Consensus Estimate: $-0.2 EPS
  • Next Year EPS Consensus Estimate: $-0.14 EPS
Additional Links:
MannKind Corp. (NASDAQ:MNKD) Chart for Sunday, July, 24, 2016